Table 3.
Characteristics of Cardiac Catheterization Procedures
Trisomy 13 (N= 17) | Trisomy 18 (N = 54) | Overall (N= 71) | ||||
---|---|---|---|---|---|---|
|
||||||
Variable | N (%)a | Median (IQR)a | N (%)a | Median (IQR)a | N (%)a | Median (IQR)a |
Age at Catheterization (months) | 18.4 (4 – 37.6) |
13.1 (5.2–38.3) |
14.4 (5 – 36.8) |
|||
Weight at Catheterization (kg) | 9.2 (5.6–13.3) |
6.1 (3.9–10.9) |
6.7 (4–11.3) | |||
Indication for Catheterization | ||||||
Heart failure/FTT | 3 (17.6) | 10 (18.5) | 13 (18.3) | |||
Significant pressure gradient | 5 (29.5) | 7 (13) | 12 (16.9) | |||
Significant shunt | 1 (5.9) | 4 (7.4) | 5 (7.0) | |||
Pulmonary hypertension | 3 (17.6) | 2 (3.7) | 5 (7.0) | |||
Cyanosis/hypercyanotic spells | 3 (17.6) | 13 (24.1) | 16 (22.6) | |||
Preoperative planning | 2 (11.8) | 17 (31.5) | 19 (26.8) | |||
Missing data | 0 | 1 (1.8) | 1 (1.4) | |||
Procedure Type | ||||||
Diagnostic | 15 (88.2) | 40 (74.1) | 55 (77.5) | |||
Interventional | 2 (11.8) | 14 (25.9) | 16 (22.5) | |||
PDA closure (% of interventional) | 0 | 2 (14.3) | 2 (12.5) | |||
Aortic valvuloplasty | 1 (50) | 0 | 1 (6.3) | |||
CoA angioplasty | 1 (50) | 2 (14.3) | 3 (18.7) | |||
Pulmonary artery angioplasty | 0 | 7 (50) | 7 (43.7) | |||
PA/RVOT stent | 0 | 2 (14.3) | 2 (12.5) | |||
Angioplasty Fontan circuit | 0 | 1 (7.1) | 1 (6.3) |
Given are frequency (N) and percent (%) for categorical variables, median and IQR for continuous variables. FTT = failure to thrive.